Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Medtronic
Mallinckrodt
Merck
Harvard Business School

Last Updated: October 1, 2022

EXEM FOAM KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Exem Foam Kit, and what generic alternatives are available?

Exem Foam Kit is a drug marketed by Giskit and is included in one NDA. There are three patents protecting this drug.

This drug has six patent family members in six countries.

The generic ingredient in EXEM FOAM KIT is air polymer-type a. There are thirty-seven drug master file entries for this compound. Additional details are available on the air polymer-type a profile page.

DrugPatentWatch® Generic Entry Outlook for Exem Foam Kit

Exem Foam Kit will be eligible for patent challenges on November 7, 2023. This date may extended up to six months if a pediatric exclusivity extension is applied to the drug's patents.

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be November 7, 2024. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

  Try it Free

Summary for EXEM FOAM KIT
International Patents:6
US Patents:3
Applicants:1
NDAs:1
DailyMed Link:EXEM FOAM KIT at DailyMed
Drug patent expirations by year for EXEM FOAM KIT
DrugPatentWatch® Estimated Generic Entry Opportunity Date for EXEM FOAM KIT
Generic Entry Date for EXEM FOAM KIT*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY
NDA:
Dosage:
FOAM;INTRAUTERINE

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for EXEM FOAM KIT

EXEM FOAM KIT is protected by three US patents and one FDA Regulatory Exclusivity.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of EXEM FOAM KIT is See Plans and Pricing.

This potential generic entry date is based on NEW CHEMICAL ENTITY.

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting EXEM FOAM KIT

Composition and method for medical imaging of body cavities
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE IN SONOHYSTEROSALPINOGRAPHY TO ASSESS FALLOPIAN TUBE PATENCY

Composition and method for medical imaging of body cavities
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE IN SONOHYSTEROSALPINOGRAPHY TO ASSESS FALLOPIAN TUBE PATENCY

Composition and method for medical imaging of body cavities
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

FDA Regulatory Exclusivity protecting EXEM FOAM KIT

NEW CHEMICAL ENTITY
Exclusivity Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for EXEM FOAM KIT

See the table below for patents covering EXEM FOAM KIT around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 2488211 Composition et procédé d'imagerie médicale de cavités corporelles (Composition and method for medical imaging of body cavities) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2011046437 See Plans and Pricing
Poland 2488211 See Plans and Pricing
Denmark 2488211 See Plans and Pricing
Netherlands 2003660 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Merck
Johnson and Johnson
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.